In both LDLR−/− and ApoE−/− mice, genetic disruption of the murine homolog of ALX/FPR2 results in reduced atherosclerosis (Petri et al., 2015a, Petri et al., 2017). The gene discussed is APOE; the disease is atherosclerosis.